Cvs Health Cdr Stock Current Valuation
CVS Stock | 16.59 0.37 2.18% |
Valuation analysis of CVS HEALTH CDR helps investors to measure CVS HEALTH's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Fundamental drivers impacting CVS HEALTH's valuation include:
Price Book 1.0614 | Enterprise Value 224.1 B | Enterprise Value Ebitda 11.4182 | Price Sales 0.3344 | Forward PE 10.8225 |
Undervalued
Today
Please note that CVS HEALTH's price fluctuation is not too volatile at this time. Calculation of the real value of CVS HEALTH CDR is based on 3 months time horizon. Increasing CVS HEALTH's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since CVS HEALTH is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CVS Stock. However, CVS HEALTH's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 16.59 | Real 18.75 | Hype 16.59 | Naive 16.77 |
The intrinsic value of CVS HEALTH's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CVS HEALTH's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CVS HEALTH CDR helps investors to forecast how CVS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CVS HEALTH more accurately as focusing exclusively on CVS HEALTH's fundamentals will not take into account other important factors: CVS HEALTH CDR Company Current Valuation Analysis
CVS HEALTH's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current CVS HEALTH Current Valuation | 224.13 B |
Most of CVS HEALTH's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CVS HEALTH CDR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, CVS HEALTH CDR has a Current Valuation of 224.13 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all Canada stocks is significantly lower than that of the firm.
CVS Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CVS HEALTH's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CVS HEALTH could also be used in its relative valuation, which is a method of valuing CVS HEALTH by comparing valuation metrics of similar companies.CVS HEALTH is currently under evaluation in current valuation category among its peers.
CVS Fundamentals
Return On Equity | 0.0602 | ||||
Return On Asset | 0.0199 | ||||
Profit Margin | 0.01 % | ||||
Operating Margin | 0.02 % | ||||
Current Valuation | 224.13 B | ||||
Shares Outstanding | 6.92 B | ||||
Price To Book | 1.06 X | ||||
Price To Sales | 0.33 X | ||||
Revenue | 370.66 B | ||||
Gross Profit | 49.25 B | ||||
EBITDA | 12.62 B | ||||
Book Value Per Share | 59.97 X | ||||
Earnings Per Share | 0.95 X | ||||
Price To Earnings To Growth | 0.66 X | ||||
Number Of Employees | 219 K | ||||
Beta | 0.53 | ||||
Market Capitalization | 123.93 B | ||||
Annual Yield | 0.04 % | ||||
Last Dividend Paid | 2.66 |
About CVS HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CVS HEALTH CDR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CVS HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CVS HEALTH CDR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with CVS HEALTH
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CVS HEALTH position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVS HEALTH will appreciate offsetting losses from the drop in the long position's value.Moving against CVS Stock
0.85 | TSLA | Tesla Inc CDR | PairCorr |
0.78 | MSFT | Microsoft Corp CDR | PairCorr |
0.7 | AVGO | Broadcom | PairCorr |
0.69 | GOOG | Alphabet CDR | PairCorr |
0.6 | NVDA | NVIDIA CDR | PairCorr |
The ability to find closely correlated positions to CVS HEALTH could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CVS HEALTH when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CVS HEALTH - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CVS HEALTH CDR to buy it.
The correlation of CVS HEALTH is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CVS HEALTH moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CVS HEALTH CDR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CVS HEALTH can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in CVS Stock
CVS HEALTH financial ratios help investors to determine whether CVS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CVS with respect to the benefits of owning CVS HEALTH security.